L.Pharma AB is a Swedish AB, operating in the Business and other management consultancy activities sector. Incorporated in 2017, the company has 0 employees and reported revenue of SEK 13.1m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall driva konsultverksamhet och service mot GxP- klassad och medicinsk utrustning.
(no translation available)
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
In its most recent annual report (2022), L.Pharma AB reported revenue of SEK 13.1m, an increase of 8% on the year before. The figures on this page draw on 5 annual filings covering 2018 to 2022. The bottom line showed a net profit of SEK 303.7k, and the EBITDA margin stood at 3.9%.
At the end of 2022, equity financed 18.2% of the balance sheet, and current assets covered short-term debt 1.5 times.
Frequently asked questions
What is the Org number of L.Pharma AB?
L.Pharma AB is registered with Bolagsverket / SCB under Org 5591238265.
What is the revenue of L.Pharma AB?
L.Pharma AB reported revenue of SEK 13.1m in 2022.
Who is the CEO of L.Pharma AB?
Leif Tore Ekberg is the CEO of L.Pharma AB, in role since 2020.
Who is the chairman of L.Pharma AB?
Anders Mattias Liss chairs the board of L.Pharma AB, in role since 2020.
